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Enhancement of the transdermal penetration of diﬀerent active agents is an important research goal. Our aim was to establish
an o v e lin vivo experimental model which provides a possibility for exact measurement of the quantity of penetrated drug. The
experiments were performed on SKH-1 hairless mice. A skin fold in the dorsal region was ﬁxed with two fenestrated titanium
plates. A circular wound was made on one side of the skin fold. A metal cylinder with phosphate buﬀer was ﬁxed into the window
of the titanium plate. The concentration of penetrated drug was measured in the buﬀer. The skin fold was morphologically intact
and had a healthy microcirculation. The drug appeared in the acceptor buﬀer after 30min, and its concentration exhibited a
continuous increase. The presence of ibuprofen was also detected in the plasma. In conclusion, this model allows an exact in vivo
study of drug penetration and absorption.
1.Introduction
T h ea b i l i t yo fv a r i o u sa g e n t st ou n d e r g ot r a n s d e r m a lp e n e -
tration is a crucial question in pharmaceutics. Transdermal
drug delivery is a useful alternative pathway for therapeutic
agents which are prone to decompose in the gastrointestinal
tract and permits the achievement of relatively high local
drug concentrations without systemic side eﬀects. However,
transdermal drug delivery per se is possible for few drugs
[1]. Accordingly, considerable research eﬀorts are focused on
physical [2]o rc h e m i c a l[ 3] methods with the aim of the
enhancement of transdermal penetration. Studies of drug
permeationandofdiﬀerentpenetration-facilitatingmethods
require appropriate models. The Franz diﬀusion cell [4]i sa n
accepted and widely applied model for dermal and transder-
mal delivery. Reconstructed human epidermis, which con-
tains viable cells, is also available and suitable for permeation
studies [5]. Other types of in vitro models include isolated
and perfused porcine forelimbs [6, 7]. Although in vitro
tests are frequently used and approved methods and their
application is strongly encouraged in order to reduce the
needforbothanimalandhumanstudies,atthepresentstage,
in vivo examinations cannot be completely dispensed within
pharmacological and dermatological studies. Many diﬀerent
types of in vivo methods have been developed. Some of them
are based on the monitoring of the eﬀects of penetrating
agents. In these models, pathological conditions are induced,
for example, renovascular hypertension [8]o rp a i n[ 9], and
amelioration of the disorder is considered proof of eﬀective
penetration. In other models, the presence of the drug in the
skin is revealed or its impact on the structure or on certain
functions of the skin is demonstrated. In such experiments,
samples are taken from the stratum corneum with a tape
stripping technique, and the penetration is analysed via
diﬀerenttypesofspectroscopy[10,11].Othermethods,such
astheassessmentoftransepidermalwaterloss,laserscanning2 The Scientiﬁc World Journal
microscopy,andlaserDopplerﬂowmetry,canalsobeutilized
in vivo in order to determine various changes in the skin
[10, 12]. Nevertheless, in contrast with the Franz diﬀusion
cell, these techniques do not provide a possibility for exact
quantitative measurement of the extent of penetration.
Accordingly, there appears to be a need for broadening of the
toolbox of models available for permeation studies.
Ourobjectivewastodevelop anovelexperimentalmodel
which permits precise determination of the quantity of drug
penetrating living full-thickness skin with a functioning
microcirculation, thereby allowing the acquisition of infor-
mation on the absorption of the studied agent. Moreover,
the detection of local side eﬀects, skin irritation, or any other
type of alteration in the skin is possible.
We chose the dorsal skin fold chamber model, which
has been used in a considerable number of experimental
physiological and pathophysiological studies for more than
twenty years [13]. A modiﬁed version of this experimental
s e t u ps e e m e dt op r o v i d ea ne ﬀective means of performing
in vivo examinations of permeation. A topical ibuprofen-
containing formulation was applied to test the model. This
agentisapotentnonsteroidalanti-inﬂammatorydrugwhich
is stable in solution and, therefore, can be used in topical
gel form and which has already been utilized in several
penetration studies [14, 15]. Beside the assessment of the
penetration and absorption of the drug, we planned to study
the morphology and the microcirculatory characteristics of
the skin in order to conﬁrm the feasibility of the model and
to estimate the potential area of its application.
2.MaterialsandMethods
2.1. Materials. I b u p r o f e nw a sf r o mS i g m a( S t .L o u i s ,M o ,
USA), Carbopol 971 from BF Goodrich Co., USA, and
polyethylene glycol 400 and triethanolamine from Hun-
garopharma Ltd. (Hungary). Methanol was of HPLC-gradi-
ent grade (Scharlau Chemie S.A., Barcelona, Spain), glacial
acetic acid and ammonium hydroxide (Merck, Darmstadt,
Germany) and potassium dihydrogenphosphate (Molar
Chemicals KFT., Budapest, Hungary) were of analytical
grade, and orthophosphoric acid and naproxen (Fluka,
Sigma-Aldrich) were of HPLC grade. Deionized HPLC-
grade water was generated by using a Milli-Q System from
Millipore (Bedford, Mass, USA).
2.2. Preparation of Ibuprofen Gel. The formulation con-
taining 5% w/w ibuprofen was prepared by the following
procedures. A 3% w/w Carbopol 971 hydrogel was prepared,
and ibuprofen dissolved in polyethylene glycol 400 with
intensive mixing was added to this gel. The pH was adjusted
with the use of triethanolamine. The control preparation
had the same composition, but without ibuprofen. Prior to
in vivo application, the preparation was carefully examined.
The gel was transparent the pH was found to be 6.2.
The rheological proﬁle of the samples was studied by Paar
Physica MCR101 rheometer (Anton Paar GmbH, Austria).
A cone-plate measuring device was used in which the cone
angle was 1 degree and the thickness of the sample was
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Figure 1: The ﬂow curves of the Carbopol 971 hydrogel (control
preparation) and ibuprofen containing formulation.
0.046mm in the middle of the cone. The measurements
were carried out at 25◦C. Flow curves of the diﬀerent
samples were determined. The shear rate was increased from
0.1 to 1001/s (up curve) and then decreased from 100 to
0.11/s (down curve). The shearing time was 300s in case
of both segments. Rheology is the study of how matters
deform and ﬂow under the inﬂuence of external forces. This
deformation is strongly inﬂuenced by the inner structure; in
thiswayrheologicalinvestigationsareusefultoolstodescribe
diﬀerent materials. In case of ﬂow curves, shear stress was
measured as the function of increasing and decreasing shear
rate. Figure 1 d e m o n s t r a t e st h eﬂ o wc u r v e so fi b u p r o f e n -
containing sample (IBU gel) and ibuprofen-free Carbopol
971 hydrogel which served as control preparation. According
to our measurements, incorporation of active pharmaceuti-
cal ingredient (ibuprofen) did not inﬂuence the viscosity of
the formulation remarkably.
2.3. Animals. The experiments were performed on 15-
week-old male SKH-1 hairless mice (body weight (bw):
36–42g). The animals were housed in plastic cages in a
thermoneutral environment with a 12h light-dark cycle
and had access to standard laboratory chow and water ad
libitum. All interventions were in full accordance with the
NIH guidelines. The procedures and protocols applied were
approved by the Ethical Committee for the Protection of
Animals in Scientiﬁc Research at the University of Szeged
(Permit number: I-74-9/2011.M´ AB).
2.4. Implantation of the Dorsal Skin Fold Chamber. Prior to
the surgical intervention, the animals were examined. Mice
with any type of injury or dermatological disorder in the
dorsalregionwerediscarded.Theanimalswereanaesthetized
intraperitoneally with a mixture of ketamine (90mg/kg bw)
and xylazine (25mg/kg bw). Two holding stitches were
inserted in the dorsal midline and exerted moderate tension
so as to form a skin fold. The entire process of the operation
wasperformedundersterilecircumstances.Twosymmetrical
titanium frames (IROLA GmbH, Schonach, Germany) were
then applied to sandwich the extended double layer of theThe Scientiﬁc World Journal 3
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Figure 2: Steps of application of skin fold chamber. (a) Titanium frames on both sides of the skin fold; (b) circular, full-dermal-thickness
wound; (c) metal cylinder containing the acceptor buﬀer (wounded side); (d) nonwounded side.
skin (Figure 2(a)). The skin fold was ﬁxed to one of the
metal frames with sutures and sandwiched securely between
the frames by means of three nuts and bolts. A circular
full-dermal-thickness wound was formed on one side of
the skin fold by removal of the complete skin down to the
musculus panniculus carnosus, thereby creating a wound
area of 66–70mm2 (Figure 2(b)). Microsurgical technique
was used for the creation of the wound. The nonwounded
skin on the opposite side still consisted of epidermis, dermis
and striated skin muscle. The wounded side was covered
with a removable thin plate of glass incorporated in one of
the titanium frames. After the operation, the animals were
returned to their cages. 24h later, they were again examined.
Signs of bleeding, infection, or any other type of disorder of
thewoundortheskinfoldwereconsideredexclusioncriteria.
The animals were anaesthetized, the glass plate was removed,
and a stainless steel cylinder with a volume of 1mL was
ﬁxed into the window of the titanium frame on the wounded
side (Figure 2(c)). The wound edges precisely matched the
aperture of the cylinder. (The creation of the wound was
achieved after marking the area with a standardized circular
ink stamp the diameter of which was the same that as of
the cylinder). The opposite, nonwounded side (Figure 2(d))
served for the application of the study formulation.
2.5. In Vivo Examination of the Penetration. The anaes-
thetized mice were placed in a lateral position on a heating
pad for maintenance of the body temperature at 37◦C. The
nonwounded side was downwards. Small supplementary
doses of ketamine and xylazine were administered when
necessary. 0.1g of the study formulation was applied to
the nonwounded side. This side was then covered with
a nonpermeable ﬁlm. 1mL of phosphate-buﬀered saline
(PBS) (pH = 7.37) was added to the metal cylinder. The
observation period lasted for 6h. After 30min, 1h, 2h, 3h,
4h, 5h, and 6h, the PBS was removed from the cylinder
(a small piece of soft plastic tube was placed onto the tip
of the sample-taking needle in order not to damage the
tissue) and was replaced by fresh PBS. The samples were
stored at −20◦C, and the concentration of the penetrated
drug was measured by means of high-performance liquid
chromatography (HPLC). At the end of the observation
period, the abdominal cavity was opened, and a blood
sample was taken from the inferior cava vein with a needle
and syringe containing 250IU of Naheparin. The blood was
then centrifuged at 3500g for 5min in order to separate
the cellular components. The plasma was removed, stored
at −20◦C, and analyzed by HPLC. The tissue layer in the
window of the skin fold chamber was removed and saved for
histological examination. At the end of the experiment, the
animals were euthanized with an overdose of ketamine.
2.6. Groups. The mice were randomly allocated into the fol-
lowing groups. Group 1 (n = 6) served for the study of
microcirculation. A dorsal skin fold was created, and the
animals were observed as described above, but no study
formulation was applied to the skin. After 6h of observation,
the metal cylinder was removed and the microcirculation4 The Scientiﬁc World Journal
of the skin was monitored by means of intravital videomi-
croscopy. In group 2 (n = 8), a control gel without drug was
applied to the skin. The animals in group 3 (n = 8) received
a formulation containing ibuprofen. In these groups, tissue
samples for histological analysis were also taken. In group 4
(n = 8) and group 5 (n = 8), a gel containing ibuprofen
was applied, and the animals were sacriﬁced after 1h or 3h,
respectively, in order to obtain blood samples at these times.
2.7. Intravital Videomicroscopy. The microcirculation was
visualized with a ﬂuorescence intravital videomicroscope
equipped with a 100W mercury lamp (Axiotech vario, Zeiss,
Jena, Germany). The anaesthetized mice received a retrobul-
bar injection of 80μL 2% ﬂuorescein isothiocyanate-labeled
dextran (molecular weight 150 kD; Sigma Chemicals, USA).
After this injection, a blue (450–490nm) ﬁlter set allowed
analysis of the microcirculation by the epi-illumination tech-
nique, using an Achroplan 20x water immersion objective.
The objective was directed towards both the wounded and
nonwounded sides of the skin fold. During examinations,
the tissue was superfused with 37◦C saline. The intravital
microscopic images were recorded with a charge-coupled
device videocamera (AVT-BC 12, AVT Horn, Aalen, Ger-
many) attached to an S-VHS video recorder (Panasonic AG-
MD830) and a personal computer. Quantitative assessment
of the microcirculatory parameters was performed oﬄine
with frame-to-frame analysis, using image analysis software
(IVM, Pictron Ltd., Budapest, Hungary). The red blood cell
velocity (RBCV, μm/s) was measured in 5 separate ﬁelds of
view, in at least 6 capillaries. The perfusion rate (PR) was
also monitored. The lengths of the perfused, functioning
vessels were determined and referred to the entire vessel
length measured in the ﬁeld of view. The PR was given as
a percentage and was determined in at least 3 diﬀerent ﬁelds
of view in each animal.
2.8. Histology. The tissue layer in the window of the titanium
chamber on the nonwounded side was excised. The biopsies
were ﬁxed in a 4% buﬀered solution of formaldehyde and
embedded in paraﬃn. The routine haematoxylin-eosin-
stained 4μm thick sections were subjected to histological
examination with a Zeiss Axioscope Z1. AxioVision software
(Zeiss Corp.) was used for the measurement of epidermal
thickness. The evaluation was performed in coded sections
by a professional pathologist (I. N´ emeth).
2.9. HPLC. The measurements were performed under the
following chromatographic conditions. The HPLC instru-
mentation included a Shimadzu CBM-20A/20Alite system
controller, a Shimadzu LC-20AD solvent delivery system, a
Shimadzu DGU-20A3 on-line degasser, a Shimadzu SPD-
M20A UV/VIS photodiode array detector, and a Shimadzu
CTO-20A column oven. The chromatographic system was
equipped with a Rheodyne Model 7725i injector (Cotati,
Calif, USA) with a 20μL loop. The chromatographic data
were collected and processed by using the Shimadzu LCso-
lution software.
Chromatographic separations were performed on a
Hichrom Kromasil 100-5C8 (150mm × 4.6mm, 5μmp a r -
ticle size) reversed-phase column (Berkshire, UK), preceded
by a Hichrom Kromasil 100-5C8 guard column. The mobile
phase consisted of 0.025M KH2PO4 buﬀer (pH = 2.7)-
methanol.Inthegradientelution ofibuprofen,themethanol
contentofthemobilephasewasincreasedlinearlyfrom40to
80% during the ﬁrst 5min and maintained at that level for a
further 8min. After the 13-min run, the methanol content
was returned to 40% during 2min, and the column was re-
equilibrated for at least 5min before the next injection. A
constant ﬂow rate of 1.00mL/min, a column temperature
of 40◦C, and a sample volume of 20μLw e r eu s e df o r
all injections. The UV detector was set at 215nm. The
mobile phase was degassed by ultrasonication before use.
The samples were prepared as follows. An aliquot of plasma
(200μL) was combined with 20μL 0.02ng/mL naproxen as
internalstandardworkingsolution.Thesamplewasacidiﬁed
by the addition of 80μL2 %H 3PO4 and diluted with 200μL
5% acetic acid solution. The mixture was centrifuged at
12000rpmfor10minat4◦C,andthesupernatantwasloaded
ontotheSupercleanLC-PhSPEtube(Sigma-Aldrich),which
had previously been conditioned with 3mL methanol and
3mL 5% acetic acid solution, under a vacuum extraction
manifold device. The cartridge was washed with 3mL H2O
and 2mL 5% acetic acid solution:MeOH (95:5 v/v). The
ibuprofen retained in the cartridge, was eluted with 2mL 5%
NH4OH solution:MeOH (5:95 v/v), and then 1mL MeOH
into a glass test-tube. The eluate was evaporated to dryness
under a stream of nitrogen at 40◦C and reconstituted with
200μL water:methanol (50:50 v/v), and 20μL was injected
into the HPLC system. PBS calibration standard solutions
was prepared by appropriate dilution of ibuprofen working
solutions with PBS in the concentration range 0.0001–
0.02ng/mL. Aliquots of 20μL PBS calibration standards and
unknown PBS samples were injected directly into the HPLC
system for analysis.
2.10. Statistical Analysis. Data analysis was performed with a
statistical software package (SigmaStat for Windows, Jandel
Scientiﬁc, Erkrath, Germany). The t-test was chosen for
the analysis of diﬀerences between the microcirculatory
data relating to the wounded and the nonwounded sides.
Diﬀerences between the measurements at diﬀerent times
were determined by repeated measure ANOVA and the
Bonferroni test as post hoc test. P<0.05 was considered
signiﬁcant. The data are reported as mean values ± standard
deviation (SD).
3. Results
3.1. Histological Analysis of the Skin Fold. The light micro-
scopic evaluation demonstrated that the skin was healthy in
all the studied groups. The photomicrographs reveal that the
epidermis was preserved. Furthermore, no alterations were
foundinthedermisorsubcutis(Figures3(a),3(b),and3(c)).
The folliculi were atrophic and occasionally cystic, proving
the hairless status of the skin (Figure 3(d)). As concernsThe Scientiﬁc World Journal 5
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Figure 3: Photomicrographs of the skin from groups 2, 5, and 1, respectively, (H&E staining). (a) Group 2, treated with ibuprofen-free gel.
(b) Group 5, exposed to ibuprofen-containing gel. (c) Group 1; no treatment was applied. (d) Atrophic folliculus.
Table 1: The microcirculatory parameters of the wounded- and
nonwounded sides. Red blood cell velocity (RBCV) and perfusion
rate (PR) values are reported as mean and standard deviation (SD).
The unit of RBCV is μm/s, the unit of PR is percent.
Wounded side Nonwounded side
RBCV Mean 595.4 502.5
SD 266.7 204.9
PR Mean 91.3 91.4
SD 4.1 2.2
the epidermal thickness, no signiﬁcant diﬀerence was found
between the groups (data not shown).
3.2. Microcirculatory Parameters. The microcirculation was
examined on both the nonwounded and wounded sides
of the skin fold. In the former location, the vessels of the
dermis close to the dermoepidermal line were visualized,
while in the latter position the microcirculation of the
striated muscle layer under the dermis was studied. Table 1
demonstrates the RBCV, the mean values of which were
found to be 502.48 and 595.41μm/s on the nonwounded and
wounded sides, respectively. The statistical analysis did not
reveal a mathematically signiﬁcant diﬀerence between the
sites. However, the data lay in a broad range, with minimum
and maximum values of 178.0 and 957.0 and of 225.0
and 1061.0μm/s on the nonwounded and wounded sides,
respectively.
The other studied parameter was the PR. High PR rates
were measured on both sides (nonwounded: mean = 91.41,
SD = 2.24; wounded: mean = 91.34, SD = 4.08), with no
signiﬁcant diﬀerence between the sides (Table 1).
3.3. Penetration and Absorption of Ibuprofen. The drug con-
centration of the buﬀer samples was referred to the area of
theskinexposedtothestudyformulation.Figure 4illustrates
the penetration of ibuprofen as a function of time. The
penetration attained a measurable value by 30min (mean
= 0.244μg/cm2,S D= 0.13). The quantity of penetrated
ibuprofen displayed a considerable elevation during the
observation period. From 3h on, the extent of penetration
was signiﬁcantly higher than that measured after 30min.
2.13% of the applied active agent entered the acceptor phase
by 6h. The calculated ﬂux at the end of the observation
period was 11.57μg/cm2/h.
The ibuprofen concentration of the plasma was deter-
minedafter1,3and6h.TheresultsarepresentedinFigure 5.
The plasma concentration was relatively low after 1h (mean
= 0.00122mg/mL, SD = 0.00102) but exhibited a signiﬁcant
increase after 3h (mean = 0.0132, SD = 0.0128). However, a
considerabledecreasewasfoundintheplasmaconcentration
of the drug by 6h (mean = 0.00571, SD = 0.0059).6 The Scientiﬁc World Journal
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Figure 4: The penetration of ibuprofen. The curve displays mean
values ± SD. The values are given in μg/cm2. ∗P<0.05 versus
30min values.
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Figure 5: The absorption of ibuprofen. The bars display mean
values ± SD. The values are given in mg/mL. ∗P<0.05 versus 1h
values.
4. Discussion
Although many diﬀerent models are used for drug penetra-
tion studies, the choice of the most appropriate model is of
great importance. Human skin would undoubtedly be the
most predictive model for such investigations, but ethical
problems and limited availability hamper its use. Hence,
various animal models have been suggested as a substitute
forhumanskin,thoughthedrugpenetrationthroughanimal
skin may diﬀer from that in human tissue [16]. It has been
reported that percutaneous absorption in monkey [17]a n d
in pig [18, 19] may closely predict that in human. However,
such large animals are not readily available and are more
expensivethansmallerlaboratoryanimals.Thus,rodentskin
is widely applied. Due to the lack of fur, some authors
have suggested the use of hairless rats [20], guinea pigs [21]
and mice [22]. Hairlessness is an important point since it
has been revealed that the number of folliculi, the opening
diameter, and the follicular volume play major roles in drug
penetration [23, 24]. Although it has been reported that
murine skin is more permeable to certain drugs than human
tissue [25], hairless mice have been applied in penetration
studies both in vitro and in vivo [26, 27], and we, therefore,
c h o s es u c ha n i m a l sf o rt h i ss t u d y .
A further signiﬁcant question is whether in vitro or in
vivo methods should be applied to clarify a certain problem.
Since the transdermal permeation of drugs and subsequent
absorption or deep tissue delivery can be inﬂuenced by many
diﬀerent factors, in vivo models feature some advantages. In
vivo examinations not only provide data on the uptake of
the drug by the circulation and on the dermal metabolism
of the active agent but also involve the use of skin the
permeability of which diﬀers from that of excised skin used
in vitro. The elastic ﬁbres which are cut during excision
seem to constrict the follicular openings, thereby reducing
the follicular reservoir and penetration pathway [28]. Our
present study, therefore, aimed to develop an experimental
modelunitingtheadvantagesofinvitroandinvivomethods,
that is, the possibility of frequent sample taking in order to
describe the penetration kinetics of the drug and the use of
intact, living skin. A dorsal skin fold chamber is an accepted
and sophisticated experimental model with which to study
the microcirculation under diﬀerent conditions, to test the
biocompatibility of diﬀerent materials [29], and to examine
angiogenesis [30] and wound healing [31]. This chamber is
tolerated by the animals even for weeks, and the literature
ﬁndings and our own results demonstrate that application
of this device does not impair the viability of the skin. The
histological analysis did not reveal any sign of tissue damage
in our experimental groups. Both the epidermis and the
deeper layers appeared to be healthy. Thus, there is good
reason to presume that the skin involved in this study had an
intact barrier function and functioning cellular components.
Beside morphological soundness, intravital microscopy con-
ﬁrmed a normal microcirculation in the applied skin fold.
We examined both the wounded and the nonwounded sides
of the skin fold. On the nonwounded side, the vessels directly
under the epidermal layer can be monitored, while assess-
ment of the wounded side visualizes the microcirculation of
the “panniculus carnosus,” the striated skin muscle under
the dermal layer. The perfusion rates of over 90% clearly
showed that both sides had an adequate blood supply. No
signiﬁcant diﬀerence in RBCV was measured between the
examined layers. However, the microcirculation displayed
heterogeneity on both sides: vessels with low and high RBCV
were seen in the same ﬁeld of view. It has been described
that timewise and spatial heterogeneity is characteristic of
the microcirculation under compromised ﬂow conditions
[32]. Nevertheless, this phenomenon cannot be considered
deﬁnitely pathologic, since laser Doppler’s measurements
have revealed that the patterns of ﬂux exhibit a marked
variabilityeveninhealthyskin[33].Insummary,thishealthy
microcirculatory network seems to provide an appropriate
environment for the absorption of the penetrated drug.
In our model, the formation of the circular wound made
the double-layered skin fold one layered on the area of the
cylinder with the acceptor phase. Thus, the drug placedThe Scientiﬁc World Journal 7
onto the nonwounded side had to penetrate one layer of
epidermis,dermis,andathinlayerofstriatedmusclepriorto
entering the acceptor buﬀer. In the event of penetration, the
active agent can be found in the acceptor phase. Our results
indicatedthatthedetectionofthepenetrationwassuccessful:
the drug appeared in the acceptor buﬀer at a measurable
rate after 30min the penetration rate increased during the
observation period. By the 6h, a ﬂux of 11.57μg/cm2/h was
measured. Earlier, in vitro studies detected a higher ﬂux
of ibuprofen, with values of 20–30μg/cm2/h or higher [14,
34]. Further, our recent study also revealed a considerably
higher rate of permeation of ibuprofen through human
epidermis [35]. The lower quantity of penetrated drug in
the present study can be explained in terms of diﬀerent
factors. In this experimental setup, the drug which crosses
the epidermis enters the dermis, where ibuprofen is exposed
to enzymatic breakdown. This enzymatic degradation leads
to a lower bioavailability of the drug [36]. Further, ibuprofen
can be taken up by the circulation. Our results conﬁrmed
the presence of the active agent in the plasma. Only that
proportion of the drug not eliminated by degradation or
removal in the circulation can be delivered towards the
deeper layer and the acceptor phase.
The signiﬁcant elevation in the plasma level of the drug
after 3h was followed by a decrease by 6h. This can be
explained by the relatively short half-life of ibuprofen, 2.2h
[37]. The ibuprofen-containing gel was applied only once, at
thebeginningoftheexperiment.Nofurtherdosesweregiven
to enhance the penetration. Hence, the processes of drug
elimination(i.e.,themetabolismandexcretionofibuprofen)
appear to come to outweigh the inﬂux of the active agent,
resulting in a lowering plasma concentration.
Characterizationoftheextentofpenetrationandabsorp-
tion is essential in order to predict the in vivo behaviour
of a formulation or to study the eﬃcacy of a penetration-
enhancing method. However, other characteristics of the
drugshouldalsobeconsidered.Ibuprofenisalipophilicdrug
which forms a reservoir in the stratum corneum [36]. The
accumulation of ibuprofen in the skin comprises 1-2μg/mg
tissue [38]. Thus, removal and homogenization of the skin
in order to determine the quantity of accumulated drug may
provide useful data during future studies with the described
model.
Overall, it can be concluded that the present experi-
mental setup is suitable for the examination of transdermal
drug penetration under in vivo circumstances. The model
provides a possibility for consecutive sample taking from
the acceptor phase, whereby repeated measurements can
be performed in the same animal in order to characterize
the kinetics of penetration. This lowers the number of
animals required for a certain study. Other experimental
setups, which allow the examination of blood samples only,
may require more animals since repeated taking of blood
quantities suﬃcient for the applied HPLC measurements
may result in hemodynamic imbalances in mice. A further
advantage of this setup is that the application of a skin
fold chamber technically facilitates intravital microscopy
by making plane tissue surfaces in the titanium windows.
Monitoring of the microcirculation may provide additional
information on the penetrating drug: as an example, vasoac-
tive agents may lead to alterations in vessel diameter or
RBCV. Furthermore, the application of a green ﬁlter set after
the administration of rhodamine-6G allows the investigator
to visualize neutrophilic granulocytes and to assess the
leukocyte-endothelial interactions. In this way, potential
irritative or inﬂammation-evoking eﬀects of formulations
can be revealed.
On the other hand, the model has the disadvantage
that a continuous presence of an investigator is required
for the assessment of the animals and for the maintenance
of anaesthesia. Moreover, the observation period with the
describedmodelwasonly6h.Althoughthismaybeextended
byfewmorehours,itisnotpossibletoperformexaminations
whose duration achieves that with the Franz diﬀusion cell.
In conclusion, we have described a new model for in vivo
penetration studies. This experimental setup allows repeated
measurements in the same animal, simultaneous studies of
penetration and absorption, and examinations of the micro-
circulation of the skin via which the penetration occurs. This
model may be a useful addition in the armamentarium of
penetration studies.
Acknowledgments
T h ea u t h o r sa r eg r a t e f u lt oL a j o sB e r k of o rm a n u f a c t u r i n g
the acceptor buﬀer-containing metal cylinders and to Mrs.
Eva Sztanyik for the excellent animal care. The study was
supported by NKTH—A∗STAR (Hungarian-Singaporean)
Bilateral S&T International Co-operation (BIOSPONA) and
T´ AMOP 4.2.1/B-09/1/KONV-2010-0005.
References
[1] H. Schaefer and T. E. Redelmeier, Skin Barrier: Principles of
Percutaneous Absorption, Karger, Basel, Switzerland, 1996.
[2] K. Yan, H. Todo, and K. Sugibayashi, “Transdermal drug
deliverybyin-skinelectroporationusingamicroneedlearray,”
International Journal of Pharmaceutics, vol. 397, no. 1-2, pp.
77–83, 2010.
[3] S. Heuschkel, J. Wohlrab, and R. H. H. Neubert, “Dermal
and transdermal targeting of dihydroavenanthramide D using
enhancer molecules and novel microemulsions,” European
Journal of Pharmaceutics and Biopharmaceutics, vol. 72, no. 3,
pp. 552–560, 2009.
[4] T. J. Franz, “Percutaneous absorption on the relevance of in
vitro data,” Journal of Investigative Dermatology, vol. 64, no. 3,
pp. 190–195, 1975.
[5] F. Netzlaﬀ,C .M .L e h r ,P .W .W e r t z ,a n dU .F .S c h a e f e r ,“ T h e
human epidermis models EpiSkin, SkinEthic and EpiDerm:
an evaluation of morphology and their suitability for testing
phototoxicity, irritancy, corrosivity, and substance transport,”
European Journal of Pharmaceutics and Biopharmaceutics, vol.
60, no. 2, pp. 167–178, 2005.
[6] S. Wagner, G. Dues, D. Sawitzky, P. Frey, and B. Christ,
“Assessment of the biological performance of the needle-
free injector INJEX using the isolated porcine forelimb,” The
British Journal of Dermatology, vol. 150, no. 3, pp. 455–461,
2004.8 The Scientiﬁc World Journal
[7] A. Mahmoud, A. Haberland, M. D¨ urrfeld, D. Heydeck,
S. Wagner, and M. Sch¨ afer-Korting, “Cutaneous estradiol
permeation, penetration and metabolism in pig and man,”
Skin Pharmacology and Physiology, vol. 18, no. 1, pp. 27–35,
2005.
[ 8 ]J .H .Z h a o ,J .H .F u ,S .M .W a n ge ta l . ,“ An o v e lt r a n s d e r m a l
patch incorporating isosorbide dinitrate with bisoprolol: in
vitro and in vivo characterization,” International Journal of
Pharmaceutics, vol. 337, no. 1-2, pp. 88–101, 2007.
[9] Y. Kolesnikov and D. Soritsa, “Analgesic synergy between
topical opioids and topical non-steroidal anti-inﬂammatory
drugs in the mouse model of thermal pain,” European Journal
of Pharmacology, vol. 579, no. 1-3, pp. 126–133, 2008.
[10] H. A. Ayala-Bravo, D. Quintanar-Guerrero, A. Naik, Y. N.
Kalia,J.M.Cornejo-Bravo,andA.Ganem-Quintanar,“Eﬀects
of sucrose oleate and sucrose laureate on in vivo human
stratum corneum permeability,” Pharmaceutical Research, vol.
20, no. 8, pp. 1267–1273, 2003.
[11] A. Teichmann, U. Jacobi, E. Waibler, W. Sterry, and J.
Lademann,“Aninvivomodeltoevaluatetheeﬃcacyofbarrier
c r e a m so nt h el e v e lo fs k i np e n e t r a t i o no fc h e m i c a l s , ”Contact
Dermatitis, vol. 54, no. 1, pp. 5–13, 2006.
[12] T.Rieger,A.Teichmann,H.Richter,S.Schanzer,W.Sterry,and
J. Lademann, “Evaluation of barrier creams—introduction
andc omparisonof3invivomethods,”ContactDermatitis,vol.
56, no. 6, pp. 347–354, 2007.
[13] M. D. Menger, M. W. Laschke, and B. Vollmar, “Viewing
the microcirculation through the window: some twenty
years experience with the hamster dorsal skinfold chamber,”
European Surgical Research, vol. 34, no. 1-2, pp. 83–91, 2002.
[14] M. Iervolino, B. Cappello, S. L. Raghavan, and J. Hadgraft,
“Penetration enhancement of ibuprofen from supersaturated
solutions through human skin,” International Journal of Phar-
maceutics, vol. 212, no. 1, pp. 131–141, 2001.
[15] Y. S. Rhee, S. Y. Chang, C. W. Park, S. C. Chi, and E.
S. Park, “Optimization of ibuprofen gel formulations using
experimental design technique for enhanced transdermal
penetration,” International Journal of Pharmaceutics, vol. 364,
no. 1, pp. 14–20, 2008.
[16] G. M. El Maghraby, B. W. Barry, and A. C. Williams, “Lipo-
somes and skin: from drug delivery to model membranes,”
European Journal of Pharmaceutical Sciences, vol. 34, no. 4-5,
pp. 203–222, 2008.
[17] R. C. Wester, P. K. Noonan, and H. I. Maibach, “Variations in
percutaneous absorption of testosterone in the rhesus monkey
duetoanatomicsiteofapplicationandfrequencyapplication,”
Archives of Dermatological Research, vol. 267, no. 3, pp. 229–
235, 1980.
[18] W. G. Reifenrath, E. M. Chellquist, E. A. Shipwash, and W. W.
Jederberg, “Evaluation of animal models for predicting skin
penetrationinman,”FundamentalandAppliedToxicology,vol.
4, no. 2, pp. S224–S230, 1984.
[19] G. A. Simon and H. I. Maibach, “The pig as an experimental
animal model of percutaneous permeation in man: qualitative
andquantitativeobservations—anoverview,”SkinPharmacol-
ogy and Applied Skin Physiology, vol. 13, no. 5, pp. 229–234,
2000.
[20] A. Rougier, C. Lotte, and H. I. Maibach, “The hairless rat:
a relevent animal model to predict in vivo percutaneous
absorption in humans?” Journal of Investigative Dermatology,
vol. 88, no. 5, pp. 577–581, 1987.
[21] K. T. Bogen, B. W. Colston, and L. K. Machicao, “Dermal
absorption of dilute aqueous chloroform, trichloroethylene,
and tetrachloroethylene in hairless guinea pigs,” Fundamental
and Applied Toxicology, vol. 18, no. 1, pp. 30–39, 1992.
[22] G. A. Simon and H. I. Maibach, “Relevance of hairless mouse
as an experimental model of percutaneous penetration in
man,” Skin Pharmacology and Applied Skin Physiology, vol. 11,
no. 2, pp. 80–86, 1998.
[ 2 3 ]N .O t b e r g ,H .R i c h t e r ,H .S c h a e f e r ,U .B l u m e - P e y t a v i ,W .
Sterry, and J. Lademann, “Variations of hair follicle size and
distribution in diﬀerent body sites,” Journal of Investigative
Dermatology, vol. 122, no. 1, pp. 14–19, 2004.
[24] N. Otberg, A. Patzelt, U. Rasulev et al., “The role of hair
follicles in the percutaneous absorption of caﬀeine,” British
Journal of Clinical Pharmacology, vol. 65, no. 4, pp. 488–492,
2008.
[25] L. M. A. Nolan, J. Corish, O. I. Corrigan, and D. Fitz-
patrick, “Combined eﬀects of iontophoretic and chemical
enhancement on drug delivery II. Transport across human,”
International Journal of Pharmaceutics, vol. 341, pp. 114–124,
2007.
[26] J. Yang, C. J. Wiley, D. A. Godwin, and L. A. Felton, “Inﬂuence
of hydroxypropyl-β-cyclodextrin on transdermal penetration
and photostability of avobenzone,” E u r o p e a nJ o u r n a lo fP h a r -
maceutics and Biopharmaceutics, vol. 69, no. 2, pp. 605–612,
2008.
[27] Y.-P. Fang, Y.-B. Huang, P.-C. Wu, and Y.-H. Tsai, “Topical
delivery of 5-aminolevulinic acid-encapsulated ethosomes in
a hyperproliferative skin animal model using the CLSM
technique to evaluate the penetration behavior,” European
Journal of Pharmaceutics and Biopharmaceutics, vol. 73, no. 3,
pp. 391–398, 2009.
[28] A. Patzelt, H. Richter, R. Buettemeyer et al., “Diﬀerential
stripping demonstrates a signiﬁcant reduction of the hair
follicle reservoir in vitro compared to in vivo,” European
Journal of Pharmaceutics and Biopharmaceutics, vol. 70, no. 1,
pp. 234–238, 2008.
[29] M. W. Laschke, A. Strohe, C. Scheuer et al., “In vivo
biocompatibility and vascularization of biodegradable porous
polyurethane scaﬀolds for tissue engineering,” Acta Biomateri-
alia, vol. 5, no. 6, pp. 1991–2001, 2009.
[30] A. Sckell and M. Leunig, “The dorsal skinfold chamber:
studying angiogenesis by intravital microscopy,” Methods in
Molecular Biology, vol. 467, pp. 305–317, 2009.
[31] H.Sorg,C.Krueger,andB.Vollmar,“Intravitalinsightsinskin
wound healing using the mouse dorsal skin fold chamber,”
Journal of Anatomy, vol. 211, no. 6, pp. 810–818, 2007.
[32] K. Vajda, A. Szab´ o, K. Kucsa, B. Suki, and M. Boros, “Micro-
circulatory heterogeneity in the rat small intestine during
compromised ﬂow conditions,” Microcirculation, vol. 11, no.
4, pp. 307–315, 2004.
[33] U. Hoﬀmann, U. K. Franzeck, M. Geiger, A. Yanar, and A.
Bollinger, “Variability of diﬀe r e n tp a t t e r n so fs k i no s c i l l a t o r y
ﬂux in healthy controls and patients with peripheral arterial
occlusive disease,” International Journal of Microcirculation,
vol. 12, no. 3, pp. 255–273, 1993.
[34] H. Swart, J. C. Breytenbach, J. Hadgraft, and J. Du Plessis,
“Synthesis and transdermal penetration of NSAID glycoside
esters,” International Journal of Pharmaceutics, vol. 301, no. 1-
2, pp. 71–79, 2005.
[35] E. Csizmazia, G. Er˝ o s ,O .B e r k e s i ,S .B e r k´ o, P. Szab´ o-R´ ev´ esz,
and E. Cs´ anyi, “Penetration enhancer eﬀect of sucrose laurate
a n dT r a n s c u t o lo ni b u p r o f e n , ”Journal of Drug Delivery Science
and Technology, vol. 21, no. 5, pp. 411–415, 2011.The Scientiﬁc World Journal 9
[36] E. Beetge, J. du Plessis, D. G. M¨ uller, C. Goosen, and F. J. van
Rensburg, “The inﬂuence of the physicochemical characteris-
tics and pharmacokinetic properties of selected NSAID’s on
their transdermal absorption,” International Journal of Phar-
maceutics, vol. 193, no. 2, pp. 261–264, 2000.
[37] W. A. Ritschel, “Pharmacokinetic and biopharmaceutical
aspects in drug delivery,” in Drug DeliveryDevices:Fundamen-
tals and Applications, P. Tyle, Ed., pp. 17–79, Marcel Dekker,
New York, NY, USA, 1988.
[38] D. A. Godwin, C. J. Wiley, and L. A. Felton, “Using cyclodex-
trin complexation to enhance secondary photoprotection of
topically applied ibuprofen,” European Journal of Pharmaceu-
tics and Biopharmaceutics, vol. 62, no. 1, pp. 85–93, 2006.